Significant Ownership of Aberdeen Group plc

Signature - Title
Cara Bird - Cara Bird / Major Shareholding Reporting Analyst
Location
Edinburgh, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Aberdeen Group plc.

Notify me when Aberdeen Group plc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Aberdeen Group plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CDXS CODEXIS, INC. Common Stock, par value $0.0001 per share 8.8% $12,985,392 +$6,315,331 7,966,498 +95% Aberdeen Group plc 31 Dec 2025
IMUX IMMUNIC, INC common stock 8.6% $6,842,471 8,243,941 Aberdeen Group plc 30 Jun 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 7.5% $10,759,045 1,321,750 Aberdeen Group plc 31 Dec 2025
SERA SERA PROGNOSTICS, INC. Class A Common Stock $0.0001 par value per share 6.1% $6,325,722 2,227,367 Aberdeen Group plc 30 Jun 2025
NSPR InspireMD, Inc. Common Stock, $0.0001 par value per share 6% $5,979,492 2,481,117 Aberdeen Group plc 01 Oct 2025
QURE uniQure N.V. Ordinary Shares, par value(euro)0.05 per share 4.8% $171,592,799 +$11,033,623 2,939,743 +6.9% Aberdeen Group plc 30 Sep 2025

Schedules 13D/G Reported by Aberdeen Group plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.